Webster Bank N. A. Has $1 Million Stake in iShares Biotechnology ETF (NASDAQ:IBB)

Webster Bank N. A. reduced its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 6.7% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 7,314 shares of the financial services provider’s stock after selling 527 shares during the period. Webster Bank N. A.’s holdings in iShares Biotechnology ETF were worth $1,004,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Capital Insight Partners LLC boosted its stake in shares of iShares Biotechnology ETF by 5.3% during the first quarter. Capital Insight Partners LLC now owns 12,926 shares of the financial services provider’s stock valued at $1,774,000 after purchasing an additional 653 shares in the last quarter. Register Financial Advisors LLC boosted its position in iShares Biotechnology ETF by 17.0% during the 1st quarter. Register Financial Advisors LLC now owns 1,034 shares of the financial services provider’s stock worth $142,000 after buying an additional 150 shares during the period. Chesley Taft & Associates LLC grew its holdings in iShares Biotechnology ETF by 1.0% during the 1st quarter. Chesley Taft & Associates LLC now owns 32,559 shares of the financial services provider’s stock worth $4,468,000 after acquiring an additional 307 shares during the last quarter. Wealth Enhancement Advisory Services LLC raised its stake in shares of iShares Biotechnology ETF by 6.7% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 39,967 shares of the financial services provider’s stock valued at $5,484,000 after acquiring an additional 2,523 shares during the last quarter. Finally, Investment Partners Asset Management Inc. acquired a new stake in iShares Biotechnology ETF in the first quarter valued at $267,000. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Down 0.5 %

Shares of NASDAQ:IBB opened at $137.26 on Friday. iShares Biotechnology ETF has a 12-month low of $111.83 and a 12-month high of $141.16. The business has a fifty day simple moving average of $134.42 and a 200 day simple moving average of $134.88.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.